NYRADA INC.

ASX: NYR
Sector
Sector:Health Care
Industry group
Industry:Pharmaceuticals, Biotechnology & Life Sciences

NYR Share Price

NYR chart by TradingView

Latest NYR ASX Announcements

  1. 30 Sept 2026 · 4:22 pmCompany Update
    Nyrada US Patent for Xolatryp Granted
  2. 25 Sept 2026 · 9:20 amSecurities Administration
    Cleansing Statement
  3. 25 Sept 2026 · 9:17 amSecurities Administration
    Application for quotation of securities - NYR
  4. 21 Sept 2026 · 9:31 amSecurities Administration
    Proposed issue of securities - NYR
  5. 21 Sept 2026 · 9:31 amSecurities Administration
    Proposed issue of securities - NYR
  6. 21 Sept 2026 · 9:31 amSecurities Administration
    Proposed issue of securities - NYR
  7. 21 Sept 2026 · 9:31 amSecurities Administration
    Proposed issue of securities - NYR
  8. 21 Sept 2026 · 9:31 amCapital Raising
    Cap Raise Deck-Building the Future of TRPC-based Therapies
  9. 21 Sept 2026 · 9:31 amCapital Raising
    Nyrada Successfully Raises AU$12.0 Million Via Placement
  10. 17 Sept 2026 · 9:14 amTrading Halt / Suspension
    Trading Halt
  11. 16 Sept 2026 · 8:31 amPresentations
    Investor Presentation- Evans&Partners Small Cap Healthcare
  12. 28 Aug 2026 · 9:36 amSubstantial Holders
    Change in substantial holding - M Azzi
  13. 24 Aug 2026 · 4:52 pmSecurities Administration
    Cleansing Statement
  14. 24 Aug 2026 · 4:50 pmSecurities Administration
    Application for quotation of securities - NYR
  15. 21 Aug 2026 · 8:50 amCompany Update
    Xolatryp Demonstrates Cardioprotection in Preclinical Study
View complete NYR announcement history →